Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 13 of 42 found articles
 
 
  Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 randomized phase II study
 
 
Title: Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 randomized phase II study
Author: Piedbois, P.
Serin, D.
Priou, F.
Laplaige, P.
Greget, S.
Angellier, E.
Teissier, E.
Berdah, J.-F.
Fabbro, M.
Valenza, B.
Herait, P.
Jehl, V.
Buyse, M.
Appeared in: Annals of oncology
Paging: Volume 18 () nr. 1 pages 52-57
Year: 2007
Contents:
Publisher: European Society for Medical Oncology
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 13 of 42 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands